BMS’ Opdivo combo approved in US for hepatocellular carcinoma
The FDA has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in combination with Yervoy (ipilimumab)
The FDA has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in combination with Yervoy (ipilimumab)
What's Your Reaction?
